Literature DB >> 7448801

Purification and characterization of a nuclear DNA-binding phosphoprotein in fetal and tumor tissues.

E Durban, D Roll, G Beckner, H Busch.   

Abstract

The basic nonhistone phosphoprotein 110/8.4 (M.W. X 10(-3)/pI) was found in 0.35 M NaCl nuclear extracts of four tumor tissues, i.e., fast-growing Novikoff hepatoma, Morris hepatoma 3924A, HeLa cells, and Namalwa cells; it was also found in fetal rat liver. This protein was not detected in normal or regenerating liver and thus may represent an "oncofetal" protein of potential interest as a cancer "marker." Protein 110/8.4 was purified approximately 4000- to 5000-fold under nondenaturing condition from 0.35 M NaCl nuclear extracts of Novikoff hepatoma cells or Namalwa cells by ammonium sulfate fractionation, calcium phosphate gel treatment, and phosphocellulose chromatography. Sodium dodecyl sulfate:polyacrylamide gel electrophoresis of the purified native protein revealed a single polypeptide chain with a molecular weight of approximately 110,000. The pI of the protein was estimated to be 8.4 by nonequilibrium pH gradient electrophoresis in 9 M urea; accordingly, this protein was designated 110/8.4. Amino acid analysis showed that Protein 110/8.4 had an acidic:basic amino acid ratio of 1.25 and a high lysine and serine content; approximately 20% of the serine residues were found to be phosphorylated. Hydrazinolysis indicated that the carboxyl-terminal amino acid was serine; the amino terminus appeared to be blocked. Binding of Protein 110/8.4 to DNA was studied by the nitrocellulose filter assay. High-affinity binding occurred at ionic strength equal to or below 0.15 M.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7448801

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Improved correlation of histological data with DCE MRI parameter maps by 3D reconstruction, reslicing and parameterization of the histological images.

Authors:  Fabian Kiessling; Martin Le-Huu; Tobias Kunert; Matthias Thorn; Silvia Vosseler; Kerstin Schmidt; Johannes Hoffend; Hans-Peter Meinzer; Norbert E Fusenig; Wolfhard Semmler
Journal:  Eur Radiol       Date:  2005-03-04       Impact factor: 5.315

2.  Comparison of nuclear proteins from DMBA-induced mammary tumors and lactating mammary glands by polyacrylamide gel electrophoresis.

Authors:  B L Dinh; L Bourget
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Microinjection of anti-topoisomerase I immunoglobulin G into nuclei of Chironomus tentans salivary gland cells leads to blockage of transcription elongation.

Authors:  E Egyházi; E Durban
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

4.  Molecular and functional diversity of non-histone protein fraction NHCP1 from hamster Kirkman-Robbins hepatoma and liver.

Authors:  Z Kiliańska; W M Krajewska; A Lipińska; L Kłyszejko-Stefanowicz
Journal:  Mol Cell Biochem       Date:  1986-08       Impact factor: 3.396

5.  Diversity of non-histone protein fraction NHCP2 from hamster Kirkman-Robbins hepatoma and liver.

Authors:  W M Krajewska; Z Kilianska; A Lipinska; L Klyszejko-Stefanowicz
Journal:  Mol Cell Biochem       Date:  1988-09       Impact factor: 3.396

6.  Phosphorylation of DNA topoisomerase II by casein kinase II: modulation of eukaryotic topoisomerase II activity in vitro.

Authors:  P Ackerman; C V Glover; N Osheroff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  Characterization of topoisomerase I and II activities in nuclear extracts during callogenesis in immature embryos of Zea mays.

Authors:  M Carballo; R Giné; M Santos; P Puigdomènech
Journal:  Plant Mol Biol       Date:  1991-01       Impact factor: 4.076

8.  Phosphorylation of human topoisomerase I by protein kinase C in vitro and in phorbol 12-myristate 13-acetate-activated HL-60 promyelocytic leukaemia cells.

Authors:  E Cardellini; E Durban
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

9.  The predominant form of mammalian DNA topoisomerase I in vivo has a molecular mass of 100 kDa.

Authors:  D S Samuels; N Shimizu
Journal:  Mol Biol Rep       Date:  1994-03       Impact factor: 2.316

10.  Topoisomerase I phosphorylation in vitro and in rapidly growing Novikoff hepatoma cells.

Authors:  E Durban; M Goodenough; J Mills; H Busch
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.